‘Robust data’ on long-term AMD treatments presented at ASRS

In this video, Anat Loewenstein, MD, MHA, of Tel Aviv Medical Center, Israel, highlights information presented at the American Society of Retina Specialists annual meeting on the management of age-related macular degeneration.“In the AMD space, we are fortunate to see new and more robust data on long-term drugs, including genetic therapies and [tyrosine kinase inhibitors], showing very good